Looking for a higher-quality, faster-time to market manufacturing solution for your protein therapeutic?
| This week's Fierce LifeSci is brought to you by AbSci.
Trouble viewing? Click here. |
| Date: Thursday, December 17, 2020 Time: 12pm ET / 9am PT Duration: 1 Hour |
|
| Are you looking for a higher-quality, faster-time to market manufacturing solution for your protein therapeutic? Learn how AbSci’s Protein PrintingTM technology has revolutionized biomanufacturing and enabled production of high quality, complex therapeutic proteins in E. coli SoluPro®. Register Now Topics covered include: Cell line design and cell screening strategies to optimize expression for antibodies and difficult-to-express proteins Cell line scalability and protein titer and quality metrics that meet pharma standards Unprecedented cell line development speed enabled by a synthetic biology-driven workflow that meets timeline needs for COVID-19 therapeutics Opportunities to simultaneously perform protein discovery and assess biomanufacturability Register Now |
|
|
| You are currently subscribed as newsletter@newslettercollector.com
If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe.
Refer to our Privacy Policy.
Fierce LifeSciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017
© 2020 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission. |
|
